Conclusion: Rasagiline is an investigational selective and irreversible inhibitor of MAO-B that has demonstrated efficacy and safety for the treatment of PD. Whether rasagiline is associated with ...

Understanding the structure-activity relationship (SAR) and mechanisms underlying MAO inhibitors is crucial but ... significantly enhanced MAO-B inhibition and increased selectivity for MAO ...

For example, based on a Parkinson's disease rating scale for motor symptoms, those on MAO-B inhibitors who then received placebo infusions scored 6.82 at the end of the year, while those taking ...

Understanding the structure-activity relationship (SAR) and mechanisms underlying MAO inhibitors is crucial but ... significantly enhanced MAO-B inhibition and increased selectivity for MAO ...

Hollander, W., Symp. Hypertension, Hahnemann Medical College and Hospital, Philadelphia (Dec. 8–12, 1958). Gertner, S., Paasonen, M., and Giarman, N. J., Fed. Proc ...